Feed the pathway they shut down.

The mevalonate pathway produces CoQ10, vitamin K2, steroid hormones, and the signaling molecules your cells need to function. When it's suppressed — by statins, by age, by nutrient deficiency — every branch suffers. This is what each branch needs.

The companion to the statins page

The statins page showed what happens when the mevalonate pathway is chronically blocked: CoQ10 depletion, K2 suppression, hormone reduction, arterial calcification. This page is the other half — what each branch of the pathway actually needs to function, and what the research says about supporting those outputs directly.

The Pathway

Six branches. Six things your body needs.

HMG-CoA reductase opens the gateway. Everything below it depends on the rate at which this enzyme operates.

CoQ10

Mitochondrial energy

The electron shuttle that powers ATP production. Your heart is the most energy-demanding muscle in your body. Depleted 16–49% by statins, and declines naturally with age.

Vitamin K2

Calcium direction

Activates MGP, the most potent known inhibitor of arterial calcification. Puts calcium in bones, keeps it out of arteries. Requires GGPP from this pathway to be synthesized.

Cholesterol

Hormone precursor

The structural precursor for every steroid hormone: testosterone, estrogen, cortisol, DHEA, aldosterone. Also the raw substrate for vitamin D synthesis from sunlight.

FPP / GGPP

Cellular signaling

Prenyl groups that anchor Ras, Rho, Rac, and Rab proteins to cell membranes. Without them: broken glucose transport, impaired immune signaling, insulin resistance.

Dolichols

Protein folding

Required for N-linked glycosylation — the process that attaches sugar chains during protein synthesis. Affects receptor function, immune recognition, and enzyme activity.

Heme A

Oxygen → ATP

Prosthetic group in Complex IV (cytochrome c oxidase) — the terminal step where electrons meet oxygen to produce water and drive ATP synthesis.

How arteries calcify.

This is the sequence. Each step has been documented independently. Together they explain the calcification paradox.

1

K2 drops. Statins reduce GGPP, the precursor UBIAD1 needs to synthesize MK-4. Animal studies show ~45% reduction in tissue K2 from atorvastatin.

2

MGP stays inactive. Without K2, Matrix Gla Protein cannot be carboxylated. Uncarboxylated MGP cannot bind calcium. The most potent calcification inhibitor in the body goes offline.

3

Calcium misplaces. Without active MGP, calcium deposits in arterial walls instead of being directed to bone. Magnesium deficiency compounds this — without Mg, calcium is less soluble and more prone to precipitation.

4

CoQ10 drops. Mitochondrial energy production declines. Oxidative stress rises. The vascular endothelium — already dealing with calcium deposits — now has less energy to maintain repair and less antioxidant protection.

5

The result: A drug prescribed to protect arteries is associated with a 5.3x increase in severe coronary calcification after 10+ years of use. Dose-dependent. Time-dependent. Documented in multiple studies.

Restoration

Supporting each branch.

CoQ10 + Selenium

CoQ10 shuttles electrons in the mitochondria and scavenges free radicals. Selenium recycles it back to its active form. The KiSel-10 trial found 53% lower cardiovascular mortality with combined CoQ10 + selenium in elderly adults — benefits persisting at 12-year follow-up. Neither nutrient alone matched this.

Forms: Ubiquinol (reduced, better absorbed over 40) or ubiquinone (oxidized, converted after ingestion). Fat-soluble — take with food containing fat.

Research dosing: 100–300 mg/day CoQ10 in heart failure trials. 200 mcg/day selenium (as selenomethionine) in KiSel-10.

Vitamin K2

K2 activates MGP (stops arterial calcification) and osteocalcin (builds bone). The Rotterdam Study: highest K2 intake = 57% lower cardiovascular death over 10 years. K1 showed no association — the forms are not interchangeable.

MK-4 (short-acting, tissue-synthesized, found in animal fats) vs. MK-7 (long-acting, bacterial, found in natto). MK-4 is the form statins directly suppress. MK-7 builds stable serum levels. Both activate MGP.

Research dosing: 180 mcg/day MK-7 improved arterial stiffness in a 3-year RCT.

Magnesium

Cofactor for 300+ enzymes. Keeps calcium soluble. Required for both steps that activate vitamin D. ~50% of Americans are below the estimated average requirement. Standard serum testing reflects less than 1% of body stores.

Forms: Glycinate (sleep/calm), malate (energy), threonate (brain), taurate (cardiovascular), citrate (general, mild laxative).

Without magnesium, sunlight exposure may not convert to active vitamin D — the cofactor is missing, not the substrate.

Sunlight (not a D3 pill)

Vitamin D is a cholesterol derivative — your skin converts 7-dehydrocholesterol to pre-vitamin D3 when exposed to UVB. The body's system is self-regulating: you cannot overdose on sun-derived vitamin D. Oral D3 supplementation bypasses these feedback controls entirely.

Sunlight delivers far more than one molecule. UVA releases nitric oxide (lowers blood pressure). Red and near-infrared light supports mitochondrial function. The full spectrum regulates circadian rhythm, serotonin, and immune function through pathways that a pill cannot replicate.

The cofactor chain: Sunlight + cholesterol → pre-D3 → liver (needs Mg) → kidney (needs Mg) → active calcitriol. K2 then directs the calcium that calcitriol mobilizes. Without K2 and Mg, the system breaks down even with adequate sun.

Cholesterol itself

The body makes ~80% of its own cholesterol because it needs it. It's the structural backbone of every cell membrane, every steroid hormone, bile acids, and the substrate for vitamin D synthesis. The brain alone contains ~20% of the body's cholesterol.

Dietary cholesterol has minimal impact on blood levels for most people — the liver adjusts production. The question is not whether cholesterol is dangerous. It's whether suppressing its synthesis has consequences we haven't fully accounted for.

Why single nutrients fail alone.

These outputs evolved as a system. Testing one in isolation while the others remain deficient is like testing one spark plug while the other three are missing.

CoQ10+Selenium

Selenium recycles oxidized CoQ10. The KiSel-10 trial showed 53% mortality reduction — together, not alone.

K2+Magnesium

K2 directs calcium to bone. Mg keeps calcium soluble in blood. Both prevent calcification through different mechanisms.

Sunlight+K2

Sun-derived D increases calcium absorption. K2 ensures that calcium goes to bone, not arteries. Without K2, more D can mean more misplaced calcium.

Sunlight+Magnesium

Magnesium is required at both hydroxylation steps that activate vitamin D. Without Mg, even adequate sun may not produce active calcitriol.

CoQ10+K2

Both are mevalonate pathway outputs. Both depleted by statins. CoQ10 powers the mitochondria in the tissues that need K2 to function.

Cholesterol+Sunlight

Cholesterol is the raw substrate for vitamin D synthesis in the skin. Reducing cholesterol synthesis reduces what the sun has to work with.

For statin users.

This is not advice to stop your medication. It is information about what the medication depletes and what the research supports as restoration.

Japan co-prescribes CoQ10

Since the 1970s, Japanese pharmaceutical companies have been required to inform patients about CoQ10 depletion. Many Japanese cardiologists co-prescribe CoQ10 with statins as standard practice. A 2023 meta-analysis confirmed CoQ10 supplementation significantly reduces statin-associated muscle pain.

K2 is not monitored

Statin users show elevated markers of vitamin K deficiency that correlate with coronary calcium scores. No major cardiology guideline currently recommends K2 monitoring or supplementation — despite the documented mechanism and the calcification data.

Magnesium deficiency overlaps

Magnesium deficiency is independently associated with increased cardiovascular risk, insulin resistance, and arterial calcification — the same conditions that led to the statin prescription. Addressing Mg status may address some of the underlying drivers.

Sunlight over supplements

Statin users whose cholesterol synthesis is reduced have less substrate for vitamin D production. Adequate sun exposure supports D status through the body's self-regulating pathway — without requiring oral supplementation that bypasses feedback controls. The cofactors (Mg, K2) must also be present.

The pathway exists whether or not a drug is involved.

CoQ10 and selenium for mitochondrial energy. K2 for calcium direction. Magnesium for calcium solubility and D activation. Sunlight for the hormone that cholesterol was supposed to become. These are not alternative medicine claims. They are biochemical predictions, confirmed by research, about what happens when you feed a pathway that produces essential molecules.

Feed the Pathway Discussion